Initiation of an investigator-initiated clinical trial of BNCT using an accelerator for primary glioblastoma, an intractable brain tumor

The University of Tsukuba is pleased to announce the launch of Boron Neutron Capture Therapy, which uses an accelerator to generate neutrons for glioblastoma, a refractory malignant brain tumor for which a treatment has not yet been established. Hereinafter referred to as “BNCT”. We will start an investigator-initiated clinical trial.

Click here for details (You will be redirected to an external site.)

By Google Translate

This entry was posted in BNCT, News, TOPNews. Bookmark the permalink.

コメントは停止中です。